It Is About Time A Women Was Made Vice President And Eventually President

Identify with the mind and with it heal the brain.

Emotional intelligence comes from emotional health.

Wisdom Education is Brain Health Education; Where Wisdom Land is a Start...

Our Education System Has Cutting Edge Mind Education While Brain Education Is Under the radar Screen.

Emotional health is the panacea for a wise America.

Use Your Brain and Mind to Improve Each Other.

Throughout history humanity has suffered greatly as the more deserving women with the greater talent for wise leadership have been unjustly deprived from ruling

Look at all the women leaders like Jascinda Ardern & Angela Markle they are doing a much better job than our male leaders like Trump and Boris Johnson. It is about time America had at least a women VP”

— Sajid Khan

RIDGEFIELD PARK, NEW JERSEY, UNITED STATES, August 8, 2020 / — What is this talk about, 'Women having symbolic power.' (NY Times)

Every vice president man or women has symbolic power but wait when the VP becomes president.

It is about time a women was made vice president and eventually president.

There is a basic fundamental scientific fact that women as leaders are far better equipped to lead as leaders of nations. Wisdom is the greatest factor in all great leadership. Wisdom is none other than emotional health. Emotional health springs from emotionally healthy brains. Traditionally men have been better at mind education but women have now caught up in mind education. In brain education women have always been far better. Both brain and mind education need to be the best in all great leaders.

When it comes to mind education women are equal to men but in brain education women take the cake. Brilliant minds every president hires but an emotionally healthy brain is a must for president's themselves as all policy is emotional policy.

Just look at the fact that all wars are started by men and all crime is committed by men. Even police shootings are by men police officers. This emotional health factor runs even in communities. Black daughters are thriving while sons are struggling.

Look at how the corona virus is being handled by women led countries!

When Trump declared his candidacy for the White House I immediately tried to point out that Trump has a brilliant mind but an insane brain and it is brain health that counts more than the mind's competence.

When vetting different candidates we must introduce the principle of vetting the brain and mind separately of each presidential candidate. Just imagine if Trump's emotionally challenged brain was vetted where America would be today.

This prejudice against women leading the country is costing us in terms of money, happiness, relationships and health etc. and not just affecting the quality of the White House leadership.

Sajid Khan
4th R Foundation
+1 201-450-8098
email us here
Visit us on social media:

My basic hypothesis that has applications in education, health, society, relationships, happiness, peace, deep brain relaxation, upbringing, wisdom, focus etc

Source: EIN Presswire

Aromajoin's digital scent hackathon successfully featured the world's first long-distance, scent-broadcasting experience

Hackaroma Finalists

On June 19th, 2020, Japanese startup Aromajoin hosted the final pitch event of 'Hackaroma,' the company's and the world's first digital scent hackathon.

Broadcasting scent over the internet is an amazing feature. We plan to make it an official function of Aroma Shooter this Fall.”

— Chu Bao Trung – Aromajoin's Software Engineering Manager

KYOTO, JAPAN, August 8, 2020 / — Japanese startup Aromajoin hosted the final pitch event of 'Hackaroma,' the company's and the world's first digital scent hackathon. Aromajoin live-streamed pitches via Zoom, where each participant demonstrated their scent projects with an Aroma Shooter, Aromajoin's own digital scent device, and a set of 6 aroma cartridges. Before each demo, viewing participants prepared their devices such that every Aroma Shooter contained the same set of matching aromas. During a demo, whenever a speaker triggered their scent cartridges, the same combination of cartridges were emitted through the devices of the viewers. In this way, Hackaroma finalists broadcasted scent over the Internet for the first time ever in real-time.

Six finalists from all over the world participated in the event. Three in Japan, one in Australia, one in Sweden, and the last in Colombia. ‘AromaDraw’, an online multiplayer game, took first place. In ‘AromaDraw,’ one player draws a picture of a common object, while an AI engine evaluates their drawing and diffuses smells through the Aroma Shooters of all other players. After smelling, players are asked to guess the subject of the drawing and assigned scores based on each person's ability to make correct judgements. Other interesting projects included using scent to help people toggle instantly between working and relaxing states of mind, controlling scent diffusion using hand gestures, an AR-based scent-matching game, a multi-sensory culinary menu, and a fantasy RPG.

Aromajoin, ecstatic about reactions to the event, intends to sponsor Hackaroma annually. The company expects future hackathons to build upon the growing functionality of the Aroma Shooter and its software.

The matte black version of the Aroma Shooter is now available at half price, USD $498, during Aromajoin's ‘Scent For All’ campaign, which ends August 31st, 2020:

The Aroma Shooter is a 6-chamber aroma emitter that completely abandons liquid media (no vapor, nor mist, nor steam). Based on Aromajoin's proprietary solid-state fragrance material, the device simply transports scented air on command, making it nearly impossible for odors to mix together unintentionally, even as scents change at high speeds. The Aroma Shooter gives creative people the means to activate and transition discrete (or blended) scents as smoothly as visual content on a screen or sound through a speaker.

Aromajoin's mission is to change the world with aroma communication. In practical terms, the startup is pioneering development of a true, end-to-end digital scent infrastructure, imagining a future where scent information travels as seamlessly as text, audio, and video.

About Aromajoin Corporation: Founded in 2012 in Kyoto, Japan, Aromajoin Corporation produces the world's most advanced aroma delivery systems, serving the needs of over 100 enterprise clients in retail, cosmetics, F&F production, entertainment, VR, and neuroscience.

Aromajoin Corporation
+81 80-9531-3091
email us here


Source: EIN Presswire

Surface Testing Technology Available Throughout the Nation Through Bactronix Franchise Network

covid-19 testing, franchise opportunity

In-home laboratory set-up makes turnaround time quick.

Surface Testing Technology Available Throughout the Nation Through Bactronix Franchise Network

MOON TOWNSHIP, PA, UNITED STATES, August 7, 2020 / — Surface testing is now attainable for organizations and households throughout the nation thanks to Bactronix and its extensive franchise network.

Bactronix, a science based microbial control company, is the first to invest in advanced technology for testing coronavirus / SARS-CoV-2 on environmental surfaces. "Since the pandemic entered the United States in January of 2020 we have been working with manufacturers of laboratory equipment to develop a testing system for surface testing of coronavirus," stated Jos Kleynjans, President and CEO of Bactronix and one of the founders of the company. "Introducing this testing technology is exciting news for our franchisees, our customers, and everyone who will utilize our services in the future."

The company has been on the front lines of the pandemic since the beginning due to its environmentally responsible, sanitizing products and hospital-grade disinfection services, including the proprietary Bactronizing® process. Bactronix also offers specialized air duct and dryer vent cleaning along with mold remediation, vapor barriers, and insecticide services.

Now, being the first company in the United States to have the ability to test for SARS-CoV-2 contamination on surfaces, Bactronix has set a new standard as a leading Microbial Control Company. "Not only do we have the ability to test the surfaces, we have a complete in-house laboratory set-up to provide quick turnaround time for test results," stated Kleynjans. According to Kleynjans, testing is applicable within a variety of settings. All tests are done by Certified Bionomic Specialists and can be done on both hard and soft surfaces in homes, schools, offices, restaurants, care facilities, medical facilities, vehicles, planes, and other settings.

Bactronix invites those interested in learning more about their testing services to their website at For those wanting to learn how to become a part of the Bactronix franchise network, visit

Bactronix is an award-winning, science-based microbial control company that uses proprietary products and advanced equipment for a wide range of disinfection and mold removal services. Their certified personnel are highly trained in administering effective, eco-responsible disinfection treatments for commercial and residential facilities. For more information on their franchise opportunity, visit

Jos Kleynjans
+1 412-375-7886
email us here
Visit us on social media:

Source: EIN Presswire

Three TensorIoT Solutions Included in AWS IoT New Solutions Launch

IRVINE, CALIF., USA, August 7, 2020 / — IRVINE, CALIF. August 8th — Amazon Web Services (AWS) announced new IoT partner solutions including TensorIoT's Rubix, SafetyVisor, and SmartInsights, all built on AWS and capable of managing IoT devices, monitoring workplace safety, and improving operational efficiency.

TensorIoT’s solutions tackle the complexity of IoT for common industry use cases and help customers accelerate time to value with a trusted advisor that has deep industry expertise to help guide the IoT journey. TensorIoT’s solutions focus on critical areas ranging from SafetyVisor's workplace safety and health protocol monitoring, to SmartInsight's rapid cloud connectivity for industrial machinery and sensors, to Rubix's easy streamlined IoT device management system.

“Having three TensorIoT solutions highlighted in AWS IoT New Solutions Launch is an honor. Our dedicted teams have worked tirelessly to ensure TensorIoT is on the leading edge of helping customers convert raw data into intelligent, actionable business outcomes,” says Ravikumar Raghunathan – CEO, TensorIoT.

About TensorIoT, Inc.: TensorIoT is an Advanced Consulting Partner with the AWS Partner Network (APN) with competencies in IoT, Machine Learning, Industrial IoT and Retail. The company also has multiple AWS IoT Service delivery credentials. Founded by a former AWS employee, TensorIoT has delivered successful projects across the world in the IoT & ML space and has offices in California, Las Vegas, Texas, Virginia, the UK, and India. TensorIoT is customer obsessed and practices the AWS leadership principles. With our deep experience delivering complete end-to-end solutions, from edge devices to end users in IoT, or data engineering to automated ML pipeline, our team of AWS certified architects can quickly assist customers in realizing their technology and business goals.

Destinee Alderete
+1 909-342-2459
email us here
Visit us on social media:

Source: EIN Presswire

Once Upon a Time All Humans Had Dark Skin

Variations in human skin color are adaptive traits that correlate closely with geography and the sun's ultraviolet radiation.

Variations in human skin color are adaptive traits that correlate closely with geography and the sun’s ultraviolet radiation.

Annual mean ultraviolet-B intensity.

Annual mean ultraviolet-B intensity.

Skin color, eye color, and hair texture are the primary ways human bodies adapt to intense sunlight in the tropics

We live in a very delicate Goldilocks balance of how much solar ultraviolet-B radiation reaches Earth’s surface and how much is absorbed by the cells making up our skin.”

— Dr. Peter L. Ward, U.S. Geological Survey retired

JACKSON, WYOMING, UNITED STATES, August 7, 2020 / — Humans thrive on Earth only when they absorb just the right intensity of just the right types of solar radiation. Low-frequency, infrared sunlight keeps us warm. Moderate-frequency visible sunlight allows us to see and powers photosynthesis, causing plants to grow. But too much high-frequency ultraviolet sunlight and neither animals nor plants flourish. Life on Earth exists only because of a very delicate Goldilocks balance in the frequencies and intensities of solar radiation reaching Earth’s surface.

Earth’s atmosphere filters sunlight. The highest energy components of sunlight, including gamma rays, X-rays, and extreme ultraviolet radiation, are completely absorbed in the uppermost atmosphere where they cause ionization of nitrogen and oxygen—forming and heating the ionosphere, 620 to 62 miles above Earth.

Ultraviolet-C solar radiation is completely absorbed primarily by molecules of oxygen, forming and heating the mesosphere and stratosphere 62 to 6 miles above Earth.

Ultraviolet-B solar radiation is absorbed by ozone molecules, forming and heating the ozone layer 22 to 9 miles above Earth. Ultraviolet-B is the highest energy solar radiation reaching Earth’s surface. But normally, 98% of all ultraviolet-B is absorbed in the ozone layer. This is fortunate because ultraviolet-B has high-enough energy to cause sunburn, skin cancer, cataracts, and disruption of DNA, ultimately causing mutations in plants and animals. Thus, too much ultraviolet-B radiation is damaging and even fatal to life on Earth.

On the other hand, solar ultraviolet-B radiation, when absorbed by human skin, forms vitamin D, which is crucial for healthy bone growth and for healthy immune systems. Furthermore, ultraviolet-B is required for healthy plant development. Thus, not enough ultraviolet-B is also damaging to life on Earth.

“The crux of this delicate Goldilocks balance,” according to Dr. Peter L. Ward, a geophysicist for 27 years with the U.S. Geological Survey, “is how much solar ultraviolet-B radiation reaches Earth’s surface and how much is absorbed by the cells making up the skin of animals and the surface layer of plants.”

The intensity and duration of sunlight is greatest in the tropics, decreasing toward the poles. The primary way our bodies adapt to these changes is by adjusting skin color, eye color, and hair texture.

Our ancestors evolved from apes in the jungles of eastern Africa 6 to 7 million years ago. Around 1.2 million years ago, as the world descended deeper into the last ice age, a megadrought drove early humans into open savannah grasslands. They began to walk upright in open sunlight. They lost their body hair, evolved more efficient perspiration, and evolved short, curly, Afro-textured hair to protect their brain from the heat of direct sunshine.

But the primary evolutionary adaptation to bright sunlight is skin color produced by melanin. Melanin is a dark brown to black pigment that occurs naturally in the hair, skin, and the iris of the eyes in people and animals. Melanin is generated by exposure to ultraviolet radiation causing tanning of skin. Melanin absorbs up to 99.9% of ultraviolet-B radiation before it can penetrate deeper into the body, where is can damage tissue and DNA. Too much ultraviolet-B radiation causes depletion of folate that is required for the body to make DNA and RNA and to metabolize amino acids.

Thus, humans living in intense sunlight in equatorial regions, long before clothes were invented, developed dark skin, short, curly, dark Afro-textured hair, and brown eyes. Beginning 70,000 to 50,000 years ago, some Homo sapiens, members of our species, began migrating out of the tropics into mid-latitudes where sunlight was less intense. At higher latitudes, they evolved lower levels of melanin, leading to lighter skin, lighter eye color, and lighter hair color so that they could absorb adequate sunlight. Plus, they evolved straighter hair that blankets the head, providing increased warmth. These lower levels of melanin appear to have evolved in a heritable way in as little as 100 generations—approximately 2500 years.

There is a very high correlation between skin color and the latitude at which a population lived for thousands of years. The less intense the sunlight, the lighter the indigenous people’s skin. That is why fair skin, blonde hair, and blue eyes are so prevalent in Scandinavia.

As humans moved to higher latitudes, they developed clothing which meant less skin was exposed to sunlight, hastening decreases in melanin. They also developed diets rich in vitamin D, such as seafood, fatty meats, egg yolks, mushrooms, and, more recently, fortified foods such as milk, orange juice, and cereals.

During the last 12,000 years, after the last ice age, humans began living in the far north. Innuit developed a diet rich in vitamin D, emphasizing fatty fish and sea mammal blubber. Eurasian populations emphasized reindeer meat, organs, and fat.

Light-skinned people can produce vitamin D in their skin at rates 5 to 10 times faster than dark-skinned people. With the rapid dispersal and mixing of populations worldwide in recent centuries, up to 50% of world population today may not get enough sun and 40% of U.S. residents are deficient in vitamin D. How much sunshine is needed for a healthy body is a function of skin color—the darker the skin, the more sunshine is required.

The intensity of sunlight in the tropics has also influenced social customs. For example, the modern siesta, a nap after a midday meal, is a common way for those working outside to avoid the most intense sunshine in the early afternoon.

Thus, the existence and health of humans and plants living on Earth is determined by having just the right Goldilocks balance between how much solar ultraviolet-B radiation is absorbed by the ozone layer versus how much reaches Earth’s surface. Human bodies adapt over thousands of years to solar intensity at the latitude where their ancestors lived. Dark skin, brown eyes, and Afro-textured hair made it possible for early humans to thrive in the bright sunlight of tropical East Africa. Lighter skin, lighter eyes, and straighter, more insulating hair made it possible for humans to survive at higher latitudes as they roamed the world in search of food.

Peter L. Ward
Science Is Never Settled Inc.
+1 3074134055
email us here
Visit us on social media:

Nina Jablonski breaks the illusion of skin color

Source: EIN Presswire

Just Released: State of China Life Science Report ahead of ChinaBio® Partnering Forum Digital

State of China Life Sciences

Virtual Partnering

ChinaBio Partnering Forum

With partnering now open for ChinaBio® Partnering Forum Digital, now is a perfect time to read the latest report from ChinaBio®, State of China Life Science.

CARLSBAD, CA, USA, August 7, 2020 / — With one-to-one partnering now open for the eleventh annual ChinaBio® Partnering Forum Digital, the largest and most productive life science partnering conference revolving around China, now is a perfect time to read the latest report from ChinaBio® Group, State of China Life Science Report – 2020 H1.

The just released special report, subtitled Back on Track – VC, Partnering and IPOs Rebound, analyzes the many factors driving China life sciences investment, including robust government support for healthcare innovation, significant VC and partnering activity, sweeping regulatory changes, and very strong cross-border pharma deals. Download the report here.

The best way to take advantage of this surge in investment activity and cross-border partnering is to participate in ChinaBio® Partnering Forum Digital, which will be presented digitally August 25–27, China Standard Time, allowing delegates to tap into China’s advanced biotech and manufacturing capabilities, access international investment, and bridge partnerships between Asia-Pacific and the Western world. 

Registration and partnering information for ChinaBio® Partnering Forum Digital is available online. 

All EBD events feature our trusted gold-standard partnering platform, partneringONE®, allowing delegates to search for and request meetings with potential partners, and then meet at prescheduled times during the conference with unique links to a secure video conferencing solution. This will be run on an extended-day, 24-hour basis to allow participants to meet conveniently from any time zone. 

In addition, company presentations will be pre-recorded and available on demand before and during the conference so that finding prospective partners will be even easier. Panels, workshops and an exhibitor showcase will also be pre-recorded and available on demand. 

For a truly global experience in this time of restricted travel, attendees from biotech, pharma, and investment sectors can access the unparalleled partnering and content offered by three upcoming events, ChinaBio® Partnering Forum Digital, BioPharm America™ Digital and BIO-Europe® Digital in August, September and October, either as individual conferences, or with a Global Partnering Virtual Passport to all three, at a substantially reduced fee. 

Registration for the Virtual Passport is available here. 

The Virtual Passport will also include complimentary access for 90-days to Biomedtracker, providing real-time analysis of major industry events, helping you stay on top of breaking news, drug pipelines, upcoming milestones, deals and companies, an invaluable resource when researching and accepting partnering meetings. With registration for one of the three events, you will also receive a 60-day free trial of Biomedtracker. 

 Additional links and information: 

Follow ChinaBio® Partnering Forum on Twitter:  @EBDGroup (hashtag: #ChinaPartnering).    

About EBD Group 

EBD Group's overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our seven landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE®, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. 

Today our events (ChinaBio® Partnering Forum, BIO-Europe®, BIO-Europe Spring®, BioPharm America™, Biotech Showcase™, China Showcase, Digital Medicine & Medtech Showcase, and BioEquity Europe) annually attract more than 12,000 senior life science executives who engage in over 48,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry. 

For more information please visit 

About ChinaBio® Group 

Since its founding in 2007, ChinaBio® Group has successfully helped nearly 100 US, European and Asia-Pacific life science companies achieve success in China. Leveraging its consulting and advisory teams’ significant experience in China’s life science industry, ChinaBio® has helped its clients identify over 1,000 in-/out-licensing and M&A opportunities and raise over $500M in funding in China. Clients have included many global pharma and life science companies as well as early stage and mid-size companies in Europe, US, Korea and Japan, as well as China. ChinaBio® has also organized over 30 conferences in China focused on investment and partnering, and publishes ChinaBio® Today, the most widely read source for China life science news. ChinaBio® Group is headquartered in Shanghai with staff in San Diego, Silicon Valley, Canada and Switzerland. 

Susanna Ling 
EBD Group 
+1 760 930 0500 

Jean Meng 
ChinaBio® Group 
+1 858 859 1860 

Susanna Ling
EBD Group
+1 760 930 0500
email us here
Visit us on social media:

Source: EIN Presswire


The Choroideremia Research Foundations Provides Education and Community about a Little Known Degenerative Eye Disease

The Choroideremia Research Foundation gave me hope and a sense of community.”

— Brian Rische, CRF member

SPRINGFIELD, MASSACHUSETTS, UNITED STATES, August 7, 2020 / — The Choroideremia Research Foundation (CRF) is celebrating 20 years of tirelessly improving the well-being of people living with choroideremia, a degenerative eye disease that mainly affects males and is little known by people. Whether it’s research, education, life-enhancing resources or access to clinical trials, the foundation is a champion and advocate for this community of roughly 6,600 people in the United States.

Choroideremia is a rare inherited form of blindness affecting approximately 1 in 50,000 people. Due to its x-linked inheritance pattern males are most severely affected with females usually experiencing much milder visual impairment. Symptoms begin in early childhood with night blindness and restriction of one’s visual field being the earliest noticeable effects, eventually progressing to complete blindness. There are currently no approved treatments for choroideremia.

The CRF has positively affected the lives of members in countless, very personal ways. Brent Rische, 26, was diagnosed when he was six-years old. Instead of given hope, he was informed of the many activities and life milestones he would miss, like playing sports and driving a car. That’s a lot for anyone, let alone a child, to accept. But with a new, patient-advocate specialist, his world changed. Brent was introduced to the CRF, learned about cutting-edge science to find a treatment and eventually qualified to participate in a gene replacement study. Today, Brent is two-plus years into a clinical trial and optimistic about his future quality of life. “I was scared and basically alone,” says Rische. “But the Choroideremia Research Foundation gave me hope and a sense of community where I got to meet and get support from so many people. When I meet new members today, now I can be the one to give them hope.”

To learn more about CHM or CRF, or to donate, please visit

Kathleen Wagner
Choroideremia Research Foundation Inc
email us here

Source: EIN Presswire

Use Of Polymer Beads As Cleaning Agents In The Soap And Cleaning Compounds Market Is Gaining Traction

Soap And Cleaning Compounds Market Report 2020-30: Covid 19 Impact And Recovery

Soap And Cleaning Compounds Global Market Report 2020-30: Covid 19 Impact And Recovery

The Business Research Company’s Soap And Cleaning Compounds Global Market Report 2020-30: Covid 19 Impact And Recovery

LONDON, GREATER LONDON, UK, August 7, 2020 / — Polymer beads are being used as cleaning agents in the soap and cleaning compounds market, to reduce water and energy consumption. Tiny, spheroidal plastic chips beads absorb stains, stray dye, and soil, carrying them away from fabrics, resulting in a cleaning process that uses less water and chemicals than traditional commercial washing machines. It also washes fabrics at lower temperatures, thereby conserving energy. For example, Xeros developed near-waterless polymer bead cleaning technology for the dry cleaning, hospitality and industrial industries.

The global soap and cleaning compounds market size is expected to decline from $187.4 billion in 2019 to $184.6 billion in 2020 at a compound annual growth rate (CAGR) of -1.6%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The global soap and cleaning compounds market size is expected to continue declining and reach $182.9 billion in 2023.

The soap and cleaning compounds manufacturing market share consists of the sales of soap and cleaning compounds by entities (organizations, sole traders or partnerships) that produce and package soaps and other cleaning compounds, surface active agents, and textile and leather finishing agents, used to reduce tension or speed the drying process.

The global soap and cleaning compounds market share is segmented by type into soap and other detergent manufacturing, surface active agent manufacturing, and polish and other sanitation goods manufacturing. By application, the market is segmented into household and commercial. By distribution channel, it is segmented into hypermarkets/supermarkets, e-commerce, pharmacy stores, and others. By category, it is segmented into mass and premium. By end use application, it is segmented into health & beauty, dishwash, clothes, and others.

Major players in the global soap and cleaning compounds market are P&G, Unilever, Ecolab Inc, S. C. Johnson & Son Inc, and Colgate-Palmolive. Asia Pacific was the largest region in the global soap and cleaning compounds market, accounting for 30% of the total share in 2019. Western Europe was the second largest region accounting for 23% of the global soap and cleaning compounds market. Africa was the smallest region in the global soap and cleaning compounds market.

Here Is A List Of Similar Reports From The Business Research Company

Soap And Other Detergents Global Market Report 2020 (

Surface Active Agents Global Market Report 2020 (

Dry-Cleaning And Laundry Services Global Market Report 2020-30: Covid 19 Impact And Recovery (

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:

Source: EIN Presswire

Companies In The Global In Vitro Diagnostics Market Share Are Investing In Strategic Collaborations And Partnerships

In-Vitro Diagnostics Market Report

In-Vitro Diagnostics Global Market Report 2020-30: Covid 19 Implications And Growth

The Business Research Company’s Global In-Vitro Diagnostics Market Report 2020-30: Covid 19 Implications And Growth

LONDON, GREATER LONDON, UK, August 7, 2020 / — Major players in the global in vitro diagnostics market share include Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc, and Thermo Fisher Scientific Inc. Companies in the global in-vitro diagnostics market are very active with multiple strategic collaborations and agreements.

Top companies in the in-vitro diagnostic market are strategically partnering and collaborating with other companies to broaden their products, technologies and services. For instance, in February 2015, Roche acquired Signature Diagnostics to strengthen its cancer diagnostics effort with Signature’s expertise in both next-generation sequencing (NGS) assays and biobanks. In February 2014, Thermo Fisher Scientific acquired Life Technologies Corporation to transform into a major player in the next-generation sequencing space.

The global in-vitro diagnostics market size is expected to grow from $57.9 billion in 2019 to $71.3 billion in 2020 at a compound annual growth rate (CAGR) of 23.2%. The growth of this market is mainly due to the increased diagnostic testing in laboratories, hospitals, and other testing sites across various countries to detect the COVID-19 virus. The need for rapid diagnostic testing such as molecular and RT-PCR based testing to identify people infected by the coronavirus is driving the in-vitro diagnostics market. The in-vitro diagnostics market size is then expected to stabilize and grow at a CAGR of 6% from 2021 and reach $81.3 billion in 2023.

North America was the largest region in the global in-vitro diagnostics market, accounting for 35% of the total share in 2019, with the US in-vitro diagnostics market capturing major share. Asia Pacific was the second largest region accounting for 31% of the global in-vitro diagnostics market share. Africa was the smallest region in the global in-vitro diagnostics market.

The in-vitro diagnostics devices (or) equipment manufacturing market consists of sales of in-vitro diagnostic equipment and related services by entities (organizations, sole traders and partnerships) that produce in-vitro diagnostics. This industry includes establishments that produce diagnostic devices used in microbiological diagnosis, hematological diagnosis, molecular diagnosis, point of care diagnosis and others.

The global in vitro diagnostics market share is segmented by type into point-of-care diagnostics devices and equipment, immunochemistry diagnostic devices and equipment, clinical chemistry diagnostics devices and equipment, molecular diagnostics devices and equipment, microbiology diagnostic devices and equipment, hemostasis diagnostic devices and equipment, hematology diagnostic devices and equipment, and immunohematology diagnostic devices and equipment. By end user, the market is segmented into hospitals and clinics, diagnostic laboratories, and others. By type of expenditure, it is segmented into public and private. By product, the market is segmented into instruments/equipment, and disposables.

Here Is A List Of Similar Reports From The Business Research Company

Microbiology Diagnostic Devices And Equipment Global Market Report 2020 (

Hematology Diagnostic Devices And Equipment Global Market Report 2020 (

Molecular Diagnostics Devices And Equipment Global Market Report 2020 (

Point-Of-Care Diagnostics Devices And Equipment Global Market Report 2020 (

Immunochemistry Diagnostic Devices And Equipment Global Market Report 2020 (

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:

Source: EIN Presswire

Healthcare Nanotechnology 2020 Market Research and Development, Future Outlook Analysis To 2024

PUNE, MAHARASTRA, INDIA, August 7, 2020 / —

Healthcare Nanotechnology Market 2020 Publish A New Market Research Report on –“ Healthcare Nanotechnology 2020 Market Research and Development, Future Outlook Analysis To 2024”.

Summary: –

It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.
The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017.

Get a Free Sample Report @

For more information or any query mail at


Teva Pharmaceuticals
Merck & Co
Gilead Sciences
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Endo International

The extensive market study presents a complete analysis of the global Healthcare Nanotechnology market, including the latest developments, current market conditions, and the growth potentialities during the review period. Accurate statistics with regard to the product, methods as well as the share belonging to the key businesses in the market are also given in the report. The market’s 360-degree appraisal also calculates the expected valuation and size of the global market throughout the given duration. The detailed evaluation of the market also throws light on the potential market size along with profit margin, product consumption, sales, exports, imports, and more. Marketing techniques, supply chain and rules that can influence the wave of the Healthcare Nanotechnology market are also covered in the report. In short, the growth scope of the market is covered in this section, elaborating on the latest market status, wherein 2019 is considered to be the base year while the ending year in the evaluation period is 2024.

Top Drivers & Key Barriers of Healthcare Nanotechnology Market Size

Besides the thorough list of the key influencers in the worldwide Healthcare Nanotechnology market, the research also outlines the intrinsic details about the pricing history coupled with the expected volume trends as well as the market size that can be anticipated in the coming years. The top drivers, lucrative opportunities combined with the key barriers are carefully appraised by our deemed experts, with the main objective of giving an extensive outline of the world industry.

Regional Insight of Healthcare Nanotechnology Market

In this section, the key regions where the Healthcare Nanotechnology market can expect to grow at varying levels during the review timeline. The latest industry dynamics, such as top influencers, barriers along with the latest developments are covered across these regions. Experts have combined both quantitative and qualitative techniques to reach macro and micro forecasts with respect to the regions and the countries across these locations. The main geographies that have been focused on in this section include Middle East & Africa, Europe, Asia Pacific, North America and Latin America. In these regions, some of the top players exercise various growth strategies to expand their business, some of which are product innovation and new launches, acquisitions, and mergers, among others. Our experts have efficiently tailored their approaching style of analyzing the market conditions in these geographies, keeping in mind the clients’ wants as well as preferences, thereby enabling them to offer accurate and actionable information with regard to the Healthcare Nanotechnology market.

Method of Research of Healthcare Nanotechnology Industry

The Healthcare Nanotechnology market-based research efficiently outlines a meticulous framework, with our experts employing the most effective possible techniques, such as the key parameters belonging to the Porter’s Five Force Model. A number of celebrated firms are given in the market study, paired with their extensive and valuable supply chain networks all over the world. The parent industry is also focused on in this section, and the macro-economic factors that can impact the global market. Our researchers have used two distinctive methods, including primary as well as secondary.

Enquiry About Report @

Table of Contents – Major Key Points

1 Market Overview

2 Manufacturers Profiles

3 Global Healthcare Nanotechnology Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

4 Global Healthcare Nanotechnology Market Analysis by Regions

5 North America Healthcare Nanotechnology by Countries

6 Europe Healthcare Nanotechnology by Countries

7 Asia-Pacific Healthcare Nanotechnology by Countries

8 South America Healthcare Nanotechnology by Countries

9 Middle East and Africa Healthcare Nanotechnology by Countries

10 Global Healthcare Nanotechnology Market Segment by Type


NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

WiseGuy Research Consultants Pvt. Ltd.
email us here

Source: EIN Presswire